"Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today."

During the past decade, Rocky Mountain Cancer Centers - Centennial conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 2 clinical trials were completed, i.e. on average, 3.5% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 1 clinical trials were completed. i.e. 2.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Cancer Centers - Centennial" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Cancer Centers - Centennial" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group (ABCSG)" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Cancer Centers - Centennial" are "Invasive Breast Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Anatomic Stage II Breast Cancer AJCC v8" (4 trials), "Breast Carcinoma" (4 trials) and "Prognostic Stage II Breast Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Rocky Mountain Cancer Centers - Centennial" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Cancer Centers - Centennial" are "Drug" (39 trials), "Biological" (34 trials), "Other" (34 trials), "Procedure" (24 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (18 trials), "Computed Tomography" (17 trials), "Quality-of-Life Assessment" (17 trials), "Questionnaire Administration" (14 trials) and "Pembrolizumab" (12 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Cancer Centers - Centennial" are 49 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Rocky Mountain Cancer Centers - Centennial". undefined are not yet recruiting, 31 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rocky Mountain Cancer Centers - Centennial, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Cancer Centers - Centennial, 1 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".